Financial statements Dcs Farmacja
Balance sheet data of DCS FARMACJA
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 2 626 032,53 | 2 831 958,32 |
| A. Fixed assets | 340 914,84 | 768 508,79 |
| B. Current assets | 2 285 117,69 | 2 063 449,53 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 2 626 032,53 | 2 831 958,32 |
| A. Equity | 666 692,07 | 643 622,22 |
| B. Liabilities and provisions for liabilities | 1 959 340,46 | 2 188 336,10 |
| I. Long-term liabilities | - | - |
| II. Short-term liabilities | 1 818 470,19 | 2 025 554,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.